ENVOY THERAPEUTICS
Envoy Therapeutics’ mission is to discover new drugs with superior efficacy and fewer side effects than existing treatments. The company’s bacTRAP® technology enables the identification of proteins in vivo that are produced by specific cell types without requiring the isolation of those cells. The technology is especially powerful in tissues of the brain, where many hundreds of cell types are intermingled. Because therapeutically modulating the activity of a specific cell type has until now been prevented by the inability to determine which proteins are uniquely expressed by that cell type, Envoy brings a new day in drug discovery.
ENVOY THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Jupiter, Florida, United States
Country:
United States
Website Url:
http://www.envoytherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
5037842159
Email Addresses:
[email protected]
Total Funding:
9.2 M USD
Technology used in webpage:
Joomla! DNS.COM Powerline
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Lorem Therapeutics
Lorem Tx is a drug discovery company translating innovative drugs from Johns Hopkins University.
Oraxion Therapeutics
Oraxion Therapeutics is a drug discovery company focused on rare and orphan diseases.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Founder
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Envoy Therapeutics
5AM Ventures
5AM Ventures investment in Series A - Envoy Therapeutics
Takeda Ventures
Takeda Ventures investment in Series A - Envoy Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Series A - Envoy Therapeutics
Official Site Inspections
http://www.envoytherapeutics.com
Unable to get host informations!!!
More informations about "Envoy Therapeutics"
Envoy Therapeutics - Company Profile - Tracxn
Envoy Therapeutics - Developer of therapeutics for neurological and psychiatric diseases. Acquired by Takeda Ventures. Raised a total funding of $8M over 2 rounds from 4 investors.See details»
Envoy Therapeutics 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Envoy Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Envoy Therapeutics - Funding, Financials, Valuation & Investors
Envoy Therapeutics is a drug discovery company focused on developing novel drugs for neurological and psychiatric diseases.See details»
Envoy Therapeutics, Inc. (acquired By Takeda Pharmaceutical)
Started with an initial $8 million financing in October 2009, Envoy Therapeutics used a proprietary technology called bacTRAP to identify target proteins expressed in the circuitry of neurological …See details»
Takeda Pharmaceutical Co. Ltd. Shells Out $140 Million for
Nov 6, 2012 OSAKA, Japan & JUPITER, Fla.-- (BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (Takeda) and Envoy Therapeutics Inc. (Envoy) jointly announced today that …See details»
Envoy Therapeutics, Inc. | LinkedIn
Envoy Therapeutics, Inc. | 205 seguidores en LinkedIn. Started with an initial $8 million financing in October 2009, Envoy Therapeutics used a proprietary technology called bacTRAP to …See details»
Takeda Acquires Envoy Therapeutics - genengnews.com
Nov 6, 2012 Takeda America Holdings will acquire Envoy Therapeutics (Envoy) to obtain access to their CNS drug pipeline. Envoy is a privately-held drug discovery company focused on …See details»
Envoy Therapeutics Company Profile | Management and
Find contact information for Envoy Therapeutics. Learn about their Manufacturing market share, competitors, and Envoy Therapeutics's email format.See details»
Envoy Therapeutics - Raised $8M Funding from 4 investors - Tracxn
3 days ago Envoy Therapeutics has raised a total funding of $8M over 2 rounds from 4 investors. Investors include Roche, 5AM Ventures and 2 others. Their latest funding round …See details»
Top 15 Contract Research Organizations (CROs) in …
In early 2022, CATO SMS merged with Pharm-Olam, a global clinical research organization delivering clinical trial services to organizations around the world. KCR – 0.15 billion USD, 700 employees KCR is a clinical development …See details»
Takeda snaps up CNS drug developer Envoy Therapeutics in …
Nov 6, 2012 The Japanese pharma giant will pay up to $140 million for Envoy Therapeutics in an upfront and milestone payments, possibly laying out some healthy returns for the investors …See details»
Elevating Outcomes - Elevar Therapeutics
A biopharmaceutical company focused on the development of oncology therapeutics and dedicated to elevating treatment experiences and outcomes for patients with limited options.See details»
Stephen Hitchcock, PhD | Parkinson's Disease
Stephen Hitchcock, PhD, is currently chief scientific officer at Takeda - Envoy (Takeda California). He has over 17 years experience in the pharmaceutical industry and has held senior …See details»
Immuno-oncology | Accession Therapeutics
Accession Therapeutics Limited is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity.See details»
Home • Allay Therapeutics
SUPPORTING PATIENTS THROUGH EVERY PHASE OF RECUPERATION The first technology designed to deliver weeks of localized pain managementSee details»
Clinical Neuroscientist, William Z. Potter, M.D., Ph.D ... - 5AM …
Clinical Neuroscientist, William Z. Potter, M.D., Ph.D., Joins Envoy’s Advisory Board Jupiter, FL – December 14, 2011 – Envoy Therapeutics, Inc., a drug discovery company, today announced …See details»
Takeda, Envoy Therapeutics form schizophrenia research alliance
Osaka, Japan | Monday, October 11, 2010, 12:00 Hrs [IST] Takeda Pharmaceutical Company Limited, a global pharmaceutical company, and Envoy Therapeutics Inc., a recently formed …See details»
Nine Square Therapeutics, Inc. (Nine Square Therapeutics, Inc.)
The ex-CEO of Cerevance and Envoy Therapeutics also has board seats at Arvinas , Neurona Therapeutics and the A-T Children’s Project. → Prostate cancer biotech ESSA Pharma has …See details»
Spotlight Therapeutics, Inc. (Spotlight Therapeutics, Inc.) - 药物管 …
The ex-CEO of Cerevance and Envoy Therapeutics also has board seats at Arvinas , Neurona Therapeutics and the A-T Children’s Project. → Prostate cancer biotech ESSA Pharma has …See details»